Atomic Artificial Enzyme for Acute and Chronic Pneumonia

Abstract Pneumonia involves complex immunological and pathological processes leading to pulmonary dysfunction, which can be life‐threatening yet lacks effective specialized medications. Natural enzymes can be used as biological agents for the treatment of oxidative stress‐related diseases, but limiting to catalytic and environmental stability as well as high cost. Herein, an artificial enzyme, gold nanoclusters (Au NCs) with excellent stability, bioactivity, and renal clearance can be used as the next‐generation biological agents for acute lung injury (ALI) and allergic lung disease (ALD). The Au 25 clusters can mimic catalase (CAT) and glutathione peroxidase (GPx), and the K m of Au 24 Er 1 with H 2 O 2 reaches 1.28 mM, about 22 times higher than natural CAT (≈28.8 mM). The clusters inhibit the oxidative stress in the mitochondria and promote the synthesis of adenosine triphosphate (ATP). The molecular mechanism shows that the TLR4/MyD88/NF‐κB pathway and M1 macrophage‐mediated inflammatory response are suppressed in ALI and the Th1/Th2 imbalance in ovalbumin (OVA)‐induced ALD is rescued. Further, the clusters can notably improve lung function in both ALI and ALD models which paves the way for immunomodulation and intervention for lung injury and can be used as a substitute for natural enzymes and potential biopharmaceuticals in the treatment of various types of pneumonia.